Cognition Therapeutics In... (CGTX)
NASDAQ: CGTX
· Real-Time Price · USD
0.33
0.01 (2.74%)
At close: May 14, 2025, 3:59 PM
0.33
-0.42%
Pre-market: May 15, 2025, 07:51 AM EDT
2.74% (1D)
| Bid | 0.32 |
| Market Cap | 20.45M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -33.3M |
| EPS (ttm) | -0.72 |
| PE Ratio (ttm) | -0.46 |
| Forward PE | -0.34 |
| Analyst | Buy |
| Ask | 0.33 |
| Volume | 771,662 |
| Avg. Volume (20D) | 1,469,873 |
| Open | 0.31 |
| Previous Close | 0.32 |
| Day's Range | 0.31 - 0.33 |
| 52-Week Range | 0.28 - 2.95 |
| Beta | 0.99 |
About CGTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CGTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CGTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+9.31%
Cognition Therapeutics shares are trading higher a...
Unlock content with
Pro Subscription
4 months ago
+27.5%
Cognition Therapeutics shares are trading higher after the company announced topline results which met its primary endpoint of safety and tolerability from its exploratory Phase 2 SHIMMER study.
1 month ago · seekingalpha.com
Cognition Therapeutics, Inc (CGTX) Q4 2024 Earnings Call TranscriptCognition Therapeutics, Inc (NASDAQ:CGTX ) Q4 2024 Results Conference Call March 20, 2025 8:00 AM ET Company Participants Mike Moyer - LifeSci Advisors Lisa Ricciardi - Chief Executive Officer John Do...